A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To assess the effectiveness of HSK7653 tablets following the substitution of daily DPP-4 inhibitor (DPP-4i) over a 24-week treatment period.
Epistemonikos ID: de774cdabdad2ffa02e187cb8e5bdcb1478adf4a
First added on: Dec 01, 2024